We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$470B
AUM Growth
+$74.8B
Cap. Flow
+$7.63B
Cap. Flow %
1.62%
Top 10 Hldgs %
30.35%
Holding
14,310
New
2,075
Increased
5,756
Reduced
4,471
Closed
1,856

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.25%
2 Technology 2.31%
3 Consumer Discretionary 1.61%
4 Financials 1.35%
5 Healthcare 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPLD icon
11601
Upland Software
UPLD
$13.7M
$54.8K ﹤0.01%
1,275
-13,166
-91% -$912K
SGMA
11602
DELISTED
Sigmatron International
SGMA
$54.7K ﹤0.01%
20,800
+848
+4% +$3.09K
VXRT
11603
DELISTED
Vaxart
VXRT
$54.7K ﹤0.01%
72,279
-257,324
-78% -$239K
LEV.WS
11604
DELISTED
The Lion Electric Company Redeemable Warrants, each whole warrant entitles the holder to purchase one Common Share at a price of $11.50 per share
LEV.WS
$54.5K ﹤0.01%
232,557
FRGE
11605
CALL
DELISTED
Forge Global Holdings
FRGE
$54.4K ﹤0.01%
2,073
+920
+80% +$25K
RVP icon
11606
PUT
Retractable Technologies
RVP
$21.6M
$54.4K ﹤0.01%
31,100
+18,400
+145% +$34.7K
GTHX
11607
CALL
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$54.4K ﹤0.01%
20,300
-12,400
-38% -$59.6K
UAVS icon
11608
AgEagle Aerial Systems
UAVS
$70.5M
$54.3K ﹤0.01%
121
-34
-22% -$15K
DC icon
11609
PUT
Dakota Gold
DC
$837M
$54.3K ﹤0.01%
+15,000
New +$49.6K
ORLA
11610
DELISTED
Orla Mining
ORLA
$54.3K ﹤0.01%
+11,429
New +$48.8K
NIU
11611
CALL
Niu Technologies
NIU
$154M
$54.2K ﹤0.01%
13,100
-13,700
-51% -$63.5K
QNTM
11612
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$131
$54.1K ﹤0.01%
537
-281
-34% -$24.1K
KRRO icon
11613
Korro Bio
KRRO
$195M
$54K ﹤0.01%
2,146
+781
+57% +$89K
BOAC.WS
11614
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$53.8K ﹤0.01%
358,677
-23,187
-6% -$4.31K
LMNL
11615
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
$53.7K ﹤0.01%
+14,133
New +$65.3K
VLN icon
11616
PUT
Valens Semiconductor
VLN
$202M
$53.3K ﹤0.01%
+16,700
New +$76.1K
NRXP icon
11617
NRX Pharmaceuticals
NRXP
$157M
$53.1K ﹤0.01%
8,062
+5,289
+191% +$53.6K
SVM
11618
CALL
Silvercorp Metals
SVM
$2.98B
$53.1K ﹤0.01%
+13,900
New +$45.7K
PTN
11619
Palatin Technologies
PTN
$18.7M
$53K ﹤0.01%
386
-472
-55% -$78.4K
CODX
11620
CALL
Co-Diagnostics
CODX
$8.8M
$52.7K ﹤0.01%
1,187
+137
+13% +$11K
NGM
11621
CALL
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$52.6K ﹤0.01%
12,900
-50,900
-80% -$235K
GWH icon
11622
PUT
ESS Tech
GWH
$14.1M
$52.5K ﹤0.01%
2,520
-727
-22% -$20.2K
ZEPP
11623
Zepp Health
ZEPP
$76.4M
$52.5K ﹤0.01%
10,024
+2,863
+40% +$20.3K
SYRS
11624
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$52.4K ﹤0.01%
19,633
-23,614
-55% -$91.5K
MIST icon
11625
CALL
Milestone Pharmaceuticals
MIST
$148M
$52K ﹤0.01%
13,200
-75,500
-85% -$276K

Similar funds

Jeff Yass's Q1 2023 Portfolio in Review

As of Q1 2023, Jeff Yass held 14,310 positions worth $470B, up 19% from $395B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q1 2023 filing shows 2,075 new, 5,756 increased, 4,471 reduced and 1,856 closed positions. Its largest new stake was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M. The largest sale was Tesla, an estimated $1.62B.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 91% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q1 2023 buy was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.22B increase.
  • Jeff Yass's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.62B.
  • Jeff Yass fully exited NextEra Energy, Inc. 5.279% Corporate Units in Q1 2023, selling an estimated $61.5M.
  • Jeff Yass's ten largest holdings make up 30% of its $470B portfolio in Q1 2023.
  • Jeff Yass opened 2,075 new positions and closed 1,856 in Q1 2023.
  • Jeff Yass's portfolio value rose 19% quarter-over-quarter to $470B.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.